Justin Bellante
Co-Founder, President and COO, BioIQ,
Southeast U.S./Caribbean
Justin Bellante is a YPO member and is the Co-founder, President and COO of BioIQ, a health technology and care navigation company that reaches two-thirds of Americans with its immunization solutions and tests for health conditions including diabetes, colon cancer, kidney disease, heart disease, COVID-19 and many others.
In response to the death a loved one, Bellante started BioIQ as an engineer who looked at the world through physics and thermodynamics — as a large system made up of smaller systems. Throughout the past 15 years, he has used that lens to innovate within the health care system, with a focus on helping millions of people more easily access and navigate the system to better understand their health and take action. Over that time, he has worked at the intersection of health plans, employers, and venture capital / private equity along with dozens of cutting-edge business partners to use technology to impact healthcare workflows and payment in consumer, employer, health plan, government, hospital and physician settings.
Bellante holds a bachelor’s degree and a master’s degree in materials engineering from Case Western Reserve University and is on leave from his doctorate program at the University of California, Santa Barbara. He has published articles in scientific journals including Science, Applied Physics Letters and MRS Proceedings, and has been featured in The Wall Street Journal.